NNIT A/S (0R5Z)
London Stock Exchange · UK · prices in DKK · close of 30 Oct 2026
Key indicators
| Last close | DKK 42.45 |
|---|---|
| 52-week range | 33.25 – 55.80 |
| Return, 1 month / 3 months | +20.3% / +12.4% |
| Return, 1 year / 3 years | −21.4% / −47.6% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 33.2% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 0.01M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NNIT is an information technology services company based in Denmark. It advises organisations on their IT systems, develops and maintains business software, and runs outsourced IT operations for its clients. Its customers are mainly companies in the life sciences industry, along with public sector bodies and other large organisations, largely in Denmark and elsewhere in Europe. The firm also offers consulting on digital transformation and the management of complex IT environments.
On this site NNIT A/S appears as a stock on the London Stock Exchange (UK), code 0R5Z, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NNIT A/S (0R5Z) trades on the London Stock Exchange in UK. It last closed at DKK 42.45 on 30 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 2,729 of 3,790 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.4% and over the last three months it rose 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 3.8% | ||
| From 52-week high | -23.9% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 12.4% | ||
| 6-month return | -4.4% | ||
| 12-month return, skipping the last month | -34.6% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 9 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M DKK | ||
| Zero-volume days | 91.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.7% |
|---|---|
| 1 month | +20.3% |
| 3 months | +12.4% |
| 6 months | −4.4% |
| 1 year | −21.4% |
| 3 years | −47.6% |
| 5 years | −65.0% |
Signals
| 50-day / 200-day average | 38.91 / 40.89 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.49 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Mar 2021 | DKK 1.0000 |
| 17 Aug 2020 | DKK 2.0000 |
| 6 Mar 2020 | DKK 2.0000 |
| 19 Aug 2019 | DKK 2.0000 |
| 8 Mar 2019 | DKK 2.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.